Nucleotide Synergy I-IV-A

Glycine max

Soybean

Tier INucleotide Synergy

Target Trait

2×

fold-change

IMP + GMP combined nucleotide synergy score

Technical Specifications

SKU

SS-F-UMA-287

Genomic Edits

GC Content

44.7-50.7%

Construct Length

3,210 bp

Promoter System

T7/SP6 cell-free

Expression System

Cell-free T7/SP6 in-vitro

Host Strain

Cell-free

Receptor Target

mGluR1 / TAS1R1-TAS1R3

IFI Score

200

Pathway Edits

GmADSS adenylosuccinate synthase overexpression for elevated IMP via de-novo purine pathway in Glycine max seed tissue
GmIMPDH2 inosine monophosphate dehydrogenase balanced overexpression for IMP/GMP co-accumulation without net IMP depletion
GmGMPS GMP synthase activity tuned to 60% of IMPDH output to maintain 1.7:1 IMP:GMP ratio for maximum synergy
GmADSL adenylosuccinate lyase upregulation ensuring AMP/IMP cycling prevents adenylate deficiency during IMP accumulation phase
GmNT5C 5′-nucleotidase expression calibrated via synthetic promoter strength to maintain free nucleotide fraction over phosphorylated forms

Key Interventions

Synergistic 5′-IMP + 5′-GMP co-accumulation at optimized 1.7:1 ratio for maximum mGluR1 and TAS1R1/TAS1R3 receptor co-activationTriple co-agonism via IMP + GMP + free glutamate co-engineering for IFI-U score multiplication beyond individual nucleotide effectsPurine pathway flux balancing preventing adenylate pool depletion while sustaining maximal IMP/GMP steady-state concentrations

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

200

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

—

IFI-F

—

Use Case

Soy-based umami concentrates, plant-based meat flavor systems, and fermented tofu products where dual-nucleotide synergy delivers maximum umami without exogenous additives. Ideal for functional food ingredient manufacturers.

License

$299 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Umami · IFI-U All Modalities